Amyloid precursor protein (APP) is a ubiquitously expressed membrane protein with a domain structure that resembles a typical membrane receptor protein.
One of the intriguing features of APP processing is that APP can be cleaved at two sites in very close proximity (separated by only 16 residues) by α-secretase or β-secretase, generating either sAPPα or the slightly smaller sAPPβ, respectively. α-Secretase cleavage is the major pathway of APP processing, which is mediated by a disintegrin and metalloproteinase ADAM10 or ADAM17. Demars and colleagues found that treatment of cells with GM6001, a broad-spectrum inhibitor of matrix-metalloproteinases and ADAMs, signifi cantly reduced proliferation of stem cells of all three origins. Importantly, they were able to rescue cell proliferation by adding purifi ed sAPPα in a dose-dependent manner. Th e stimulatory action of sAPPα on stem cell proliferation was independent of epidermal growth factor and basic epidermal growth factor, which are the known stimulators of stem cell proliferation [2] . Using specifi c inhibitors of kinase path ways, Demars and colleagues demonstrated that ERK signaling is involved downstream of the proliferating eff ects of sAPPα.
Th is study by Demars and colleagues adds to previous studies demonstrating the neuroprotective and neuroproliferative eff ects of sAPPα on adult neurons [2, 3] . Indeed, mice lacking APP (APP-KO) show smaller brain size and reduced body growth [4] and studies show that expression of sAPPα alone can rescue the growth and brain weight defi cits [5] . Th us, there is now overwhelming evidence that sAPPα exerts a positive, growth-promoting eff ect on both neuronal precursor stem cells as well as adult neurons. Th e novel conclusion of this study is that sAPPα is a general proliferation factor for stem cells of multiple lineages since APP is ubiquitously expressed and since sAPPα stimulates proliferation of diverse stem cell populations.
What remains unknown is whether sAPPβ, the fragment 16 residues shorter than sAPPα, also exerts similar eff ects. Since sAPPα and sAPPβ are generated in a roughly 9:1 ratio, the biological eff ects of sAPPβ, unless dramatically diff erent from those of sAPPα, are likely to be marginal on neuronal stem cells. A recent study from the Allinquant group [6] shows that both sAPPα and sAPPβ stimulated axon growth via ERK activation and the LaFerla group [7] reported that amino-terminally secreted products of APP, and in particular sAPPβ, caused a rapid and robust diff erentiation of pluripotent human embryonic stem cells toward a neural fate. Together, these studies suggest that APP processing has a stimulating eff ect on both neural stem cell proliferation and diff erentiation. However, the overall eff ects of APP processing on neural stem cell proliferation and diff erentia tion are likely to be more complex since APP processing also generates Aβ and AICD fragments, which have been shown to exert a negative infl uence on neurogenesis [8, 9] .
Th e identity of the membrane protein that binds sAPPα and acts as a receptor to activate the intracellular ERK signaling pathway remains unknown. One intriguing possibility is that sAPPα binds uncleaved, membranebound APP since APP has been shown to form homodimers in cis and in trans through its extracellular portion. Moreover, APP has been known to activate the ERK pathway through its intracellular domain [10] . Future studies will be needed to test this hypothesis.
Although the biological consequences of APP-processing on neural stem cell proliferation and diff erentiation are likely to be complex, these studies of Demars and colleagues and Freude and colleagues indicate that sAPPα/sAPPβ can be harnessed to generate large numbers of neural precursor cells and neurons from human embryonic stem cells. Th is has the potential for new approaches to study the physiological as well as pathological roles of APP.
